SI
CDMO

Sapience Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Sapience Investments’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201,880
Closed -$2.3M – 91
2024
Q3 		$2.3M Sell
201,880
-590
-0.3% -$5.92K 1.14% 48
2024
Q2 		$1.45M Buy
+202,470
New +$1.55M 0.74% 62

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Sapience Investments's CDMO Position: Q4 2024 in Review

Sapience Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 201,880 shares — an estimated $2.3M sold.

Sapience Investments first reported a position in CDMO in Q2 2024 and held it in 2 quarters. The position peaked at $2.3M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Sapience Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Sapience Investments sold 201,880 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $2.3M.
  • Sapience Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Sapience Investments's Avid Bioservices, Inc. Common Stock position peaked at $2.3M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Sapience Investments's 13F filing for Q4 2024, filed 14 Feb 2025.